GLP-3 ( Reta ) Peptide COAs

GLP-3 RT / Reta batches are independently analyzed by
Freedom Diagnostics
to verify product identity, purity, and net peptide content.

The available certificates cover
10mg, 20mg, and 30mg
batches, with identity confirmed as
GLP RT
through analytical testing.

Verified Batch Results

For the
10mg
batches, lot
2026-03-001-A1
reports
99.837% purity
with
11.46 mg
net peptide content; lot
2026-03-002-A1
reports
99.91% purity
with
11.48 mg;
and lot
2026-03-003-A1
reports
99.88% purity
with
11.52 mg.

For the
20mg
batches, lot
2026-03-001-A2
reports
99.911% purity
with
21.92 mg
net peptide content, while lot
2026-03-002-A2
reports
99.96% purity
with
25.96 mg.

For the
30mg
batches, lot
2026-03-001-A3
reports
99.909% purity
with
37.07 mg
net peptide content, while lot
2026-03-002-A3
reports
99.27% purity
with
31.34 mg.

Storage Information

Specific storage conditions are
not listed
on the Freedom Diagnostics Certificates of Analysis for these
GLP-3 RT / Reta
batches. The corresponding lots include
2026-03-001-A1,
2026-03-002-A1,
2026-03-003-A1,
2026-03-001-A2,
2026-03-002-A2,
2026-03-001-A3,
and
2026-03-002-A3.

HPLC + Mass Spectrometry

Analytical testing for all
GLP-3 RT / Reta
batches was performed using
HPLC with UV detection coupled with mass spectrometry (LC-MS).

Mass spectrometry
was used to confirm the identity of
GLP RT,
while
HPLC-UV
was used to report the purity results for each tested batch.